792 related articles for article (PubMed ID: 28715655)
1. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.
Yuan D; Zhao Y; Banks WA; Bullock KM; Haney M; Batrakova E; Kabanov AV
Biomaterials; 2017 Oct; 142():1-12. PubMed ID: 28715655
[TBL] [Abstract][Full Text] [Related]
2. β2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier.
Gorina R; Lyck R; Vestweber D; Engelhardt B
J Immunol; 2014 Jan; 192(1):324-37. PubMed ID: 24259506
[TBL] [Abstract][Full Text] [Related]
3. Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.
Papademetriou I; Tsinas Z; Hsu J; Muro S
J Control Release; 2014 Aug; 188():87-98. PubMed ID: 24933603
[TBL] [Abstract][Full Text] [Related]
4. Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.
Hsu J; Rappaport J; Muro S
Pharm Res; 2014 Jul; 31(7):1855-66. PubMed ID: 24558007
[TBL] [Abstract][Full Text] [Related]
5. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages.
Park S; Kang S; Chen X; Kim EJ; Kim J; Kim N; Kim J; Jin MM
Biomaterials; 2013 Jan; 34(2):598-605. PubMed ID: 23099063
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycan-mediated dynamin-dependent transport of neural stem cell exosomes in an in vitro blood-brain barrier model.
Joshi BS; Zuhorn IS
Eur J Neurosci; 2021 Feb; 53(3):706-719. PubMed ID: 32939863
[TBL] [Abstract][Full Text] [Related]
8. A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells.
Lee HM; Choi EJ; Kim JH; Kim TD; Kim YK; Kang C; Gho YS
Biochem Biophys Res Commun; 2010 Jun; 397(2):251-6. PubMed ID: 20529672
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions.
Osada-Oka M; Shiota M; Izumi Y; Nishiyama M; Tanaka M; Yamaguchi T; Sakurai E; Miura K; Iwao H
Hypertens Res; 2017 Apr; 40(4):353-360. PubMed ID: 27881852
[TBL] [Abstract][Full Text] [Related]
10. In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors.
Papademetriou IT; Garnacho C; Schuchman EH; Muro S
Biomaterials; 2013 Apr; 34(13):3459-66. PubMed ID: 23398883
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.
Ju Z; Ma J; Wang C; Yu J; Qiao Y; Hei F
Inflammation; 2017 Apr; 40(2):486-496. PubMed ID: 28000095
[TBL] [Abstract][Full Text] [Related]
12. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
13. Exosomes as Tools to Suppress Primary Brain Tumor.
Katakowski M; Chopp M
Cell Mol Neurobiol; 2016 Apr; 36(3):343-52. PubMed ID: 26983831
[TBL] [Abstract][Full Text] [Related]
14. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
15. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
[TBL] [Abstract][Full Text] [Related]
16. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
17. Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo.
Fu L; Shi B; Wen S; Morsch M; Wang G; Zhou Z; Mi C; Sadraeian M; Lin G; Lu Y; Jin D; Chung R
Acta Biomater; 2022 Jul; 147():403-413. PubMed ID: 35605956
[TBL] [Abstract][Full Text] [Related]
18. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.
Tosi G; Duskey JT; Kreuter J
Expert Opin Drug Deliv; 2020 Jan; 17(1):23-32. PubMed ID: 31774000
[No Abstract] [Full Text] [Related]
20. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
